Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A phase II randomized placebo‐controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance

The Prostate(2020)10.1002/pros.24076Source: DataRank Database

A phase II randomized placebo‐controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance is a research paper published in The Prostate (2020). On theSindex it has a DataRank of 0. It has been cited 36 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

36 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Topics (20)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Mikolaj Filon,Wei Huang ORCID,Tom Havighurst,Katina DeShong ORCID,KyungMann Kim ORCID

Live enrichment

PubMed:33095939

NIH HHS

Grant: NIH N01 (CN35156)

MeSH Terms

HumansFruitProstatic NeoplasmsKallikreinsProstate-Specific AntigenInsulin-Like Growth Factor IInsulin-Like Growth Factor Binding Protein 3Plant ExtractsAntineoplastic Agents, PhytogenicPlacebosBiopsyPhytotherapyMiddle AgedMaleWatchful WaitingBiomarkers, TumorPomegranate

Keywords

Pomegranateprostate cancerActive Surveillance